Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Wierzbicki, Michael R  [Clear All Filters]
Journal Article
J. C. Dombrowski, Wierzbicki, M. R., Newman, L. M., Powell, J. A., Miller, A., Dithmer, D., Soge, O. O., and Mayer, K. H., Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial, Clin Infect Dis, 2021.
C. W. Woods, Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., DeRaad, D. E. Poer, Amanna, I. J., Slifka, M. K., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C., and Walter, E. B., An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults., Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study., Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
K. Page, Melia, M. T., Veenhuis, R. T., Winter, M., Rousseau, K. E., Massaccesi, G., Osburn, W. O., Forman, M., Thomas, E., Thornton, K., Wagner, K., Vassilev, V., Lin, L., Lum, P. J., Giudice, L. C., Stein, E., Asher, A., Chang, S., Gorman, R., Ghany, M. G., T Liang, J., Wierzbicki, M. R., Scarselli, E., Nicosia, A., Folgori, A., Capone, S., and Cox, A. L., Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection., N Engl J Med, vol. 384, no. 6, pp. 541-549, 2021.
C. R. Cohen, Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., and Hemmerling, A., Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis., N Engl J Med, vol. 382, no. 20, pp. 1906-1915, 2020.
J. D. Klausner, Bristow, C. C., Soge, O. O., Shahkolahi, A., Waymer, T., Bolan, R. K., Philip, S. S., Asbel, L. E., Taylor, S. N., Mena, L. A., Goldstein, D. A., Powell, J. A., Wierzbicki, M. R., and Morris, S. R., Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study., Clin Infect Dis, 2020.
J. M. Marrazzo, Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., and Schwebke, J., Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial., Clin Infect Dis, vol. 68, no. 5, pp. 803-809, 2019.
S. N. Taylor, Marrazzo, J., Batteiger, B. E., Hook, E. W., Seña, A. C., Long, J., Wierzbicki, M. R., Kwak, H., Johnson, S. M., Lawrence, K., and Mueller, J., Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea., N Engl J Med, vol. 379, no. 19, pp. 1835-1845, 2018.